A Safety and Immunogenicity Trial in Adults 65 Years of Age or Over to Prevent Influenza

Summary

The objective of this study is to evaluate the safety of the vaccine and the immune response to the vaccine in healthy adult volunteers 65 years of age or older. Volunteers will be assigned by randomization to receive either the vaccine or an inactive substance (placebo) by injections in the arm on two occasions over one month. The study will last approximately 10 months and will have a total of 7 visits.

Timeline

Start

2008-06

Primary completion

2008-09

Completion

2009-03

Drugs

Indications